THE USE OF THE KARNOFSKY PERFORMANCE SCALE IN DETERMINING OUTCOMES AND RISK IN GERIATRIC OUTPATIENTS

被引:251
作者
CROOKS, V [1 ]
WALLER, S [1 ]
SMITH, T [1 ]
HAHN, TJ [1 ]
机构
[1] VET ADM MED CTR W LOS ANGELES, GERIATR RES EDUC & CLIN CTR, LOS ANGELES, CA USA
来源
JOURNALS OF GERONTOLOGY | 1991年 / 46卷 / 04期
关键词
D O I
10.1093/geronj/46.4.M139
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
The Karnofsky Performance Scale (KPS) was evaluated in a geriatric outpatient population with regard to three issues: its strength of association with widely used and validated geriatric instruments; its ability to predict patient outcomes; and its ability to serve as an identifier of high-risk patients. The 134-patient sample was given a comprehensive geriatric assessment which included the KPS, the Activities of Daily Living (ADL) scale, the Instrumental Activities of Daily Living (IADL) scale, and other psychosocial and sensory tests. The KPS, ADL, and IADL were significantly correlated with each other, and the KPS showed the strongest associations with other functional measures. The KPS was also highly predictive of outcomes, performing better or equally well as the ADL and IADL. The KPS designation of high- and low-risk groups resulted in statistically significant score differences between groups in all but one assessment area, demonstrating better ability to discriminate than either the ADL or IADL. Thus, the KPS was shown to serve as an effective proxy score for a patient's health and functional status. It also was a significant predictor of hospitalizations, survival time, community residence, and institutionalization. Finally, the KPS was shown to adequately distinguish risk groups to aid in the targeting of services to ambulatory geriatric patients.
引用
收藏
页码:M139 / M144
页数:6
相关论文
共 40 条
[1]   PHASE-II TRIAL OF OUTPATIENT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMA, CHRONIC LYMPHOCYTIC-LEUKEMIA, AND SELECTED SOLID TUMORS [J].
ALLISON, MAK ;
JONES, SE ;
MCGUFFEY, P .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :75-80
[2]  
*AM ASS RET PERS, 1987, PROF OLD AM
[3]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[4]  
BOMBARDIER C, 1982, J RHEUMATOL, V9, P753
[5]   QUALITY OF LIFE IN CANCER TRIALS [J].
BRINKLEY, D .
BRITISH MEDICAL JOURNAL, 1985, 291 (6497) :685-686
[6]   CHRONIC DISEASE, FUNCTION AND THE QUALITY OF CARE [J].
CLUFF, LE .
JOURNAL OF CHRONIC DISEASES, 1981, 34 (07) :299-304
[7]   THE QUALITY OF LIFE OF PATIENTS WITH END-STAGE RENAL-DISEASE [J].
EVANS, RW ;
MANNINEN, DL ;
GARRISON, LP ;
HART, LG ;
BLAGG, CR ;
GUTMAN, RA ;
HULL, AR ;
LOWRIE, EG .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (09) :553-559
[8]   RISK-FACTORS AFFECTING READMISSION OF THE ELDERLY INTO THE HEALTH-CARE SYSTEM [J].
FETHKE, CC ;
SMITH, IM ;
JOHNSON, N .
MEDICAL CARE, 1986, 24 (05) :429-437
[9]  
Fillenbaum G, 1988, MULTIDIMENSIONAL FUN